Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,142	1,043	2,853	416	1,944
Short-Term Investments	12,454	19,434	9,837	22,316	29,125
Trading Asset Securities	-	-	-	-	4
Cash & Short-Term Investments	13,596	20,477	12,690	22,732	31,073
Cash Growth	-33.60%	61.36%	-44.18%	-26.84%	153.84%
Accounts Receivable	11,874	11,463	11,566	10,952	11,479
Other Receivables	3,967	3,314	3,978	3,577	4,266
Receivables	15,841	14,777	15,544	14,529	15,745
Inventory	10,654	10,851	10,189	8,981	9,059
Other Current Assets	2,807	4,253	4,910	5,017	3,816
Total Current Assets	42,898	50,358	43,333	51,259	59,693
Property, Plant & Equipment	21,530	20,682	21,864	19,276	17,721
Long-Term Investments	1,527	2,108	15,382	14,926	21,348
Goodwill	71,264	68,527	67,783	51,375	49,208
Other Intangible Assets	53,731	55,411	64,900	43,370	25,146
Long-Term Deferred Tax Assets	7,400	6,600	1,800	4,800	1,600
Other Long-Term Assets	9,810	9,710	11,439	12,199	6,760
Total Assets	208,160	213,396	226,501	197,205	181,476
Accounts Payable	5,240	5,633	6,710	6,809	5,578
Accrued Expenses	12,269	12,005	9,224	8,316	7,671
Short-Term Debt	154	3,196	8,096	385	605
Current Portion of Long-Term Debt	3,016	3,778	2,270	2,570	1,636
Current Portion of Leases	330	356	527	620	449
Current Income Taxes Payable	3,103	2,910	2,349	1,587	1,266
Current Unearned Revenue	784	1,511	2,700	2,520	3,067
Other Current Liabilities	12,088	13,606	15,918	19,331	22,399
Total Current Liabilities	36,984	42,995	47,794	42,138	42,671
Long-Term Debt	61,856	57,802	61,813	33,205	36,195
Long-Term Leases	2,291	2,286	2,626	2,597	2,510
Pension & Post-Retirement Benefits	2,041	2,115	2,167	2,250	3,724
Long-Term Deferred Tax Liabilities	2,401	2,122	640	1,023	349
Other Long-Term Liabilities	15,812	17,579	22,173	20,075	18,564
Total Liabilities	121,385	124,899	137,213	101,288	104,013
Common Stock	481	480	478	476	473
Additional Paid-In Capital	94,469	93,603	92,631	91,802	90,591
Retained Earnings	114,610	116,725	118,353	125,656	103,394
Treasury Stock	-115,015	-114,763	-114,487	-113,969	-111,361
Comprehensive Income & Other	-8,069	-7,842	-7,961	-8,304	-5,896
Total Common Equity	86,476	88,203	89,014	95,661	77,201
Minority Interest	299	294	274	256	262
Shareholders' Equity	86,775	88,497	89,288	95,917	77,463
Total Liabilities & Equity	208,160	213,396	226,501	197,205	181,476
Total Debt	67,647	67,418	75,332	39,377	41,395
Net Cash (Debt)	-54,051	-46,941	-62,642	-16,645	-10,322
Net Cash Per Share	-9.46	-8.24	-10.97	-2.90	-1.81
Filing Date Shares Outstanding	5,686	5,667	5,647	5,619	5,623
Total Common Shares Outstanding	5,686	5,667	5,646	5,616	5,620
Working Capital	5,914	7,363	-4,461	9,121	17,022
Book Value Per Share	15.21	15.56	15.77	17.03	13.74
Tangible Book Value	-38,519	-35,735	-43,669	916	2,847
Tangible Book Value Per Share	-6.77	-6.31	-7.73	0.16	0.51
Land	299	291	353	368	423
Buildings	9,744	9,036	9,046	8,832	9,001
Machinery	21,855	20,612	19,661	17,373	16,710
Construction In Progress	4,805	4,937	5,925	4,875	3,822

Source: S&P Global Market Intelligence. Standard template. Financial Sources.